Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001655759-25-000075
Filing Date
2025-04-29
Accepted
2025-04-29 17:06:20
Documents
24
Period of Report
2025-06-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A arvn-20250429.htm   iXBRL DEF 14A 1058563
6 arvn-20250429_g1.jpg GRAPHIC 50501
7 arvn-20250429_g2.jpg GRAPHIC 46054
8 arvn-20250429_g3.jpg GRAPHIC 140485
9 arvn-20250429_g4.jpg GRAPHIC 78777
10 arvn-20250429_g5.jpg GRAPHIC 82334
11 arvn-20250429_g6.jpg GRAPHIC 70719
12 arvn-20250429_g7.jpg GRAPHIC 461146
13 arvn-20250429_g8.jpg GRAPHIC 186982
  Complete submission text file 0001655759-25-000075.txt   4404707

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20250429.xsd EX-101.SCH 2833
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arvn-20250429_def.xml EX-101.DEF 3435
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20250429_lab.xml EX-101.LAB 4001
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20250429_pre.xml EX-101.PRE 2492
26 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20250429_htm.xml XML 140165
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38672 | Film No.: 25889095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)